Back to
ALPS ADVISORS INC
KNSA
Showing 0 of 14 quarters
Position history for
ALPS ADVISORS INC's holdings in KINIKSA PHARMACEUTICALS-A
As of its Q1 2024 13F, ALPS Advisors held 28,203 shares of KNSA (Kiniksa Pharmaceuticals), worth $556,445. ALPS Advisors' 13F filings listed KNSA from Q2 2023 to Q1 2024, 4 quarterly filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.